Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Kineret Market Size Forecast: How Big Could The Market Get By 2030?
Historical expansion during that era was primarily fueled by the unaddressed requirements in inflammatory conditions, the clinical accomplishments of IL-1 blockade, more effective diagnosis of rare syndromes, the integration of biologics by healthcare facilities, and the accessibility of extensive long-term safety data.
Future growth is projected to stem from the increasing identification of autoinflammatory diseases, the broadening of their application into new treatment areas, the rising use of biologics in pediatric patients, enhanced access to specialized medical care, and continuous innovation in biologic therapies. Concurrently, significant developments anticipated during this time frame encompass the expanded deployment of IL-1 inhibitors, an escalation in the management of autoinflammatory conditions, an increase in inflammatory care provided to children, a clear preference for targeted cytokine-based treatments, and greater application in rare inflammatory syndromes.
Get A Free Sample Report With In-Depth Market Insights:
Kineret Market Growth Catalysts And Demand Drivers
The kineret market is anticipated to expand due to the increasing incidence of autoimmune diseases. These disorders refer to a set of conditions where the body’s immune system erroneously attacks its own cells, tissues, and organs, perceiving them as foreign invaders. The growing prevalence of autoimmune diseases is linked to a blend of genetic, environmental, and lifestyle elements. Kineret is a medication that proves beneficial in addressing autoimmune diseases, especially in managing conditions involving excessive inflammation caused by the immune system targeting the body’s tissues. For instance, in May 2023, according to the National Institute for Health and Care Research (NIHR), a UK-based health and care research organization, a study of 22 million people reveals that autoimmune disorders now impact approximately one in ten individuals, with 19 autoimmune diseases affecting around 10% of the population, 13% of women, and 7% of men. Consequently, the rising prevalence of autoimmune diseases is fueling the growth of the kineret market.
Kineret Market Segment Outlook: Which Categories Are Growing Fastest?
The kineret market covered in this report is segmented –
1) By Indication: Treatment Of Rheumatoid Arthritis, Treatment Of Still’s Disease, Treatment Of Cryopyrin-Associated Periodic Syndromes, Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMIDN)
2) By Formulation: Injectable formulation, Pre-filled Syringes Or Auto-injectors
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesalers And Distributors
5) By End-User: Hospitals, Specialty Clinics, Outpatient Treatment Centers, Home Healthcare Providers
Kineret Market Trends Shaping Long-Term Demand
A primary development in the kineret market is the integration of strategic collaborations to develop cutting-edge Kineret-based offerings and achieve a market lead. These alliances enable companies within the Kineret market to consolidate assets and specialized knowledge, enhance their research and development endeavors, broaden their market footprint, and accelerate the commercialization of products, thereby fostering creativity and expansion in the sector. For instance, in May 2024, Swedish Orphan Biovitrum AB, a biopharmaceutical firm from Sweden, collaborated with Handok Inc., a pharmaceutical entity based in South Korea, to introduce Kineret (anakinra) in South Korea. This partnership unites Handok’s regional insights with Sobi’s international biopharmaceutical strengths, especially in the field of rare illnesses.
Kineret Market Leading Companies And Competitive Benchmarking
Major companies operating in the kineret market are Sobi (Swedish Orphan Biovitrum AB)
View The Full Kineret Market Report:
Kineret Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the kineret market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kineret market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
